TP53 and acute myeloid leukemia: Given that P53-MDM2 pathway is frequently dysregulated in AML (39-42), we hypothesize that Np17 may play a critical role in dysregulated P53 of AML, and its mechanism may be involved in recruiting nuclear MDM2 to P53 for ubiquitin-mediated degradation in cells.